Literature DB >> 8770310

Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.

L V Owens1, L Xu, G A Dent, X Yang, G C Sturge, R J Craven, W G Cance.   

Abstract

BACKGROUND: The FAK gene encodes a 125-kDa tyrosine kinase (p125FAK) involved in signal transduction pathways used in cell adhesion, motility, and anchorage-independent growth. Because thyroid carcinomas have a wide variability in their propensity for invasion and metastasis, we studied the expression of FAK in a variety of thyroid tissues.
METHODS: We synthesized a recombinant N-terminal fragment of the human FAK protein and developed a specific polyclonal antisera. Using Western blot analysis, we assessed the levels of p125FAK expression in 30 human thyroid tissue samples from 27 patients that included paired normal and malignant specimens. Levels of FAK protein in individual tumors were quantitated by densitometric scanning of the immunoblots, and the results were correlated with tumor histology and biologic behavior.
RESULTS: The levels of FAK expression were directly correlated with thyroid carcinomas demonstrating the most aggressive phenotypes. The highest levels of p125FAK were seen in follicular carcinomas and tumors associated with distant metastatic foci. In contrast, neoplastic thyroid tissues with limited invasive potential, such as papillary carcinomas, follicular adenomas, and other nonmalignant thyroid lesions, showed minimal p125FAX expression.
CONCLUSIONS: Overexpression of FAK may be part of a mechanism for invasion and metastasis of thyroid cancer. Furthermore, the levels of p125FAK may serve as a marker of biologic behavior in this disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770310     DOI: 10.1007/bf02409059

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  22 in total

Review 1.  Thyroid cancer: a lethal endocrine neoplasm.

Authors:  J Robbins; M J Merino; J D Boice; E Ron; K B Ain; H R Alexander; J A Norton; J Reynolds
Journal:  Ann Intern Med       Date:  1991-07-15       Impact factor: 25.391

2.  Activated ras oncogenes in human thyroid cancers.

Authors:  N R Lemoine; E S Mayall; F S Wyllie; C J Farr; D Hughes; R A Padua; V Thurston; E D Williams; D Wynford-Thomas
Journal:  Cancer Res       Date:  1988-08-15       Impact factor: 12.701

3.  Expression of focal adhesion kinase gene and invasive cancer.

Authors:  T M Weiner; E T Liu; R J Craven; W G Cance
Journal:  Lancet       Date:  1993-10-23       Impact factor: 79.321

4.  Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings.

Authors:  H Gharib; J R Goellner; A R Zinsmeister; C S Grant; J A Van Heerden
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

5.  Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase.

Authors:  L Kornberg; H S Earp; J T Parsons; M Schaller; R L Juliano
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

Review 6.  Molecular basis of epithelial tumorigenesis: the thyroid model.

Authors:  D Wynford-Thomas
Journal:  Crit Rev Oncog       Date:  1993

7.  Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors.

Authors:  T M Weiner; E T Liu; R J Craven; W G Cance
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

8.  A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.

Authors:  A Fusco; M Grieco; M Santoro; M T Berlingieri; S Pilotti; M A Pierotti; G Della Porta; G Vecchio
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962

9.  Overexpressed Csk tyrosine kinase is localized in focal adhesions, causes reorganization of alpha v beta 5 integrin, and interferes with HeLa cell spreading.

Authors:  M Bergman; V Joukov; I Virtanen; K Alitalo
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

10.  Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly.

Authors:  K Burridge; C E Turner; L H Romer
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  69 in total

Review 1.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 2.  Distinguishing benign from malignant thyroid lesions: galectin 3 as the latest candidate.

Authors:  R V Lloyd
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 3.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

4.  Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.

Authors:  Maria P Torres; Moorthy P Ponnusamy; Subhankar Chakraborty; Lynette M Smith; Srustidhar Das; Hwyda A Arafat; Surinder K Batra
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

5.  SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer.

Authors:  Won Gu Kim; Celine J Guigon; Laura Fozzatti; Jeong Won Park; Changxue Lu; Mark C Willingham; Sheue-yann Cheng
Journal:  Clin Cancer Res       Date:  2012-01-23       Impact factor: 12.531

6.  Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro.

Authors:  D Ilić; O Genbacev; F Jin; E Caceres; E A Almeida; V Bellingard-Dubouchaud; E M Schaefer; C H Damsky; S J Fisher
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 7.  Targeting the p53 pathway.

Authors:  Vita M Golubovskaya; William G Cance
Journal:  Surg Oncol Clin N Am       Date:  2013-07-30       Impact factor: 3.495

8.  RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.

Authors:  Megumi Iiizumi; Sucharita Bandyopadhyay; Sudha K Pai; Misako Watabe; Shigeru Hirota; Sadahiro Hosobe; Taisei Tsukada; Kunio Miura; Ken Saito; Eiji Furuta; Wen Liu; Fei Xing; Hiroshi Okuda; Aya Kobayashi; Kounosuke Watabe
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

Review 9.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

10.  Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study.

Authors:  Sang Jin Kim; Jin Woo Park; Ji Sung Yoon; Ji O Mok; Yeo Joo Kim; Hyeong Kyu Park; Chul Hee Kim; Dong Won Byun; Yong Jin Lee; So Young Jin; Kyo Il Suh; Myung Hi Yoo
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.